Management of older patients presenting with non-ST-elevation acute coronary syndrome

EuroIntervention 2018;14:e258-e260 published online e-edition June 2018. DOI: 10.4244/EIJV14I3A44

Danny Chan
Danny Chan1, MBBS, PhD; Lucy Lawson1, MRes; Vijay Kunadian1,2*, MBBS, MD, FRCP
1. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; 2. Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, United Kingdom

Medical management with a view to invasive therapy in adults with non-ST-elevation myocardial infarction (NSTEMI)1 is the recommended standard of care. However, older patients are significantly less likely to receive pharmacological therapies and undergo invasive management, such as angiography and percutaneous coronary intervention (PCI), compared to younger patients. This may partly explain why older people are more likely to have adverse outcomes following acute coronary syndrome (ACS), with a 15.7x increased odds of in-hospital mortality in patients ≥85 years old compared to those <45 years2. The global population is ageing and consequently the number of older patients presenting with ACS ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Do we still need single-sex clinical trials in cardiology?

Latest news